Abstract
Fibrous dysplasia is known to be associated with various endocrinopathy such as true precocious puberty. We will report a case of fibrous dysplasia observed in a 13-year-old girl which developed widely in her facial bones, associated with increased growth hormone levels. Debulking surgery was performed, and thereafter, CB-154 (bromocriptine) was administered to correct increased growth hormone levels in the patient. Subsequently, growth hormone levels were regulated, and no local recurrence was observed as of approximately one year postoperatively.
